Navigation Links
UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease
Date:10/18/2010

ATLANTA, Oct. 18 /PRNewswire/ -- Findings from the PRECiSE 3 (P3) open label extension study for Cimzia® (certolizumab pegol; CZP), demonstrating the longest continuously running maintenance trial for an anti-TNF in Crohn's disease, will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology (ACG), taking place in San Antonio from October 15 – 20.  Additionally, long-term efficacy data from the PRECiSE 4 (P4) clinical trial also will be presented at the meeting.

Results of the P3 open-label extension study showed that continuous therapy with Cimzia provided long-term remission for more than 4.5 years in patients who initially responded to Cimzia in the six-month PRECiSE 2 study (P2).  In the PRECISE 2 double blind, placebo controlled clinical trial, 48% of patients achieved remission at six months.  Sustained long-term remission was observed among patients who had previous anti-TNF exposure (77% remission), as well as anti-TNF naive patients (73% remission).  

Similarly, results of the P4 open-label extension study showed long-term remission rates among patients treated with Cimzia (naive – 63%; non-naive – 50%).  For some patients, disease remission was achieved in as early as 4 weeks (38% of patient population).  Additionally, the data demonstrates that patients who are losing response to Cimzia or experience an interruption in therapy can be recaptured with one additional dose of Cimzia.  The data suggests re-induction therapy may have long-term benefits in helping patients who experienced drug interruption or loss of initial response achieve response and maintain remission.

"Collectively, these Cimzia data findings are important for patients living with moderate to severe Crohn's disease and the gastroenterologists treating them, as long-term remission is the ultimate goal of treatment," said Cem Kayhan, MD, Medical Director at UCB.  "It
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
3. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
8. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
11. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast ... diabetes (T1D) is an autoimmune disease that permanently destroys beta ... can no longer produce insulin. Over the last 90 years, ... other treatment can be offered to a patient who is ... different times of action - long-acting as well as short ...
(Date:5/27/2015)... NEW YORK , May 27, 2015  Precision ... announced the findings from its 2015 Digital Trends Study ... decision makers are aware of the concepts of big ... fully implement them.  The Health Information ... incentives for healthcare providers to make use of electronic ...
(Date:5/27/2015)... , May 27, 2015  LumiThera Inc., ... non-invasive photobiomodulation (PBM) treatment for ocular disorders and ... Washington State Life Sciences ... 3 recipients of the LSDF matching grants worth ... treatment for subjects with dry age-related macular degeneration ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3LumiThera Receives LSDF Commercialization Grant Award 2
... , LAVAL, QC, Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. ... it has filed a New Drug Submission (NDS) with ... novel formulation of the antidepressant trazodone. , "We are ... Canada," said James R. Howard-Tripp, President and Chief Executive ...
... WORTH, Texas, Aug. 4 Of the 600,000-800,000 people trafficked across international ... by 2010, human trafficking will be the No. 1 crime worldwide. ... chairman of the department of forensic and investigative Genetics and co-director of ... University of North Texas (UNT) Health Science Center , ...
Cached Medicine Technology:Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3DNA Helps Reunite Children With Their Families 2DNA Helps Reunite Children With Their Families 3
(Date:5/27/2015)... The BBB Code of Business Practices ... enhance customer trust and confidence in business. The Code ... principles that summarize important elements of creating and maintaining ... business accreditation by BBB. Businesses based in the United ... application procedures will be accredited by BBB. , To ...
(Date:5/27/2015)... Continuing its commitment to finding a cure ... community, SmartPractice® donated $25,000 to HonorHealth Breast ... Vice President of Human Resources Meg Mosher and SmartScrubs ... to Paulla Miller, Sherry Gage, Dr. Linda Greer and ... on April 30. The center is located at 19646 ...
(Date:5/27/2015)... Allred Dental located in San Marcos, CA ... need extensive dental treatment - understand the oral issues they ... their problems. , Dr. Jeff Allred calls it “Dental Case ... assessment of the patient’s oral health and problems together with ... oral health problems. , “The dental case planning process starts ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Black ... customer satisfaction surveys in the multiple services and ... to determine the highest ranked Electronic Health and ... of a special research focus on implemented EHR ... those software vendors with the highest scores in ...
(Date:5/27/2015)... May 27, 2015 The MedSpa at ... FDA-approved dermal filler treatments in Abilene, Texas: Xeomin®, Belotero ... the appearance of glabellar lines, better known as the ... Balance® is designed to treat smoker’s lines around the ... chin, while Radiesse® improves the appearance of smile lines ...
Breaking Medicine News(10 mins):Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
... , FRIDAY, Aug. 5 (HealthDay News) -- Smoking ... atrial fibrillation, a new study warns. U.S. researchers reviewed ... who were followed for an average of 13 years, and ... time. The risk of the abnormal heart rhythm was ...
... (HealthDay News) -- Children with HIV who receive antiretroviral ... (lipid) levels, and would benefit from guidelines aimed at ... findings are published in JAIDS: Journal of Acquired ... first crucial step in minimizing cardiovascular disease complications and ...
... in Spanish . , ANN ARBOR, Mich. ... be used safely and effectively even in tumors from the ... the University of Michigan Comprehensive Cancer Center. Sentinel lymph ... first node where cancer would likely spread. If that node ...
... --,Smokers who take a multivitamin pill may think they can ... affects of cigarettes, according to a new study. Researchers ... will reduce their risk of cancer, allowing them to light ... a virtuous behavior for a subsequent indulgence, known as the ...
... WHAT: Scientists from around the world will gather ... order to improve health through advances in pharmaceutical sciences ... In recognition of AAPS,s 25th anniversary, this year,s meeting, ... sessions, including more than 60 symposia and roundtables. ...
... , THURSDAY, Aug. 4 (HealthDay News) -- American military veterans ... suicide than fellow students who have never been in the ... poll paints a grave picture of these students, mental health: ... they have considered suicide at some point in their lives, ...
Cached Medicine News:Health News:Children's HIV Drugs May Cause High Cholesterol 2Health News:Sentinel node biopsy safe, effective in head and neck melanomas, U-M study finds 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:Many Military Vets in College Plagued By Thoughts of Suicide 2Health News:Many Military Vets in College Plagued By Thoughts of Suicide 3
... 6-Place Rotor has a standard 1.5ml rotor and ... adapters. Easy operation (no switches to mess with). ... press the plastic tab to open. Starts and ... and 2000 x g. Only five inches in ...
... which allows user to stop rotor before opening ... stainless steel pin is virtually indestructible. Lid release ... microcentrifuge tubes at low to medium speed (up ... inch x 6 inch footprint. Starts and stops ...
Inquire...
Inquire...
Medicine Products: